Dr. Gordon G Liu is a PKU Yangtze River Scholar Professor of Economics at Peking University National School of Development (NSD), and Director of PKU China Center for Health Economic Research (CCHER). His research interests include health and development economics, health reform, and pharmaceutical economics.
Prior to PKU NSD, he was a full professor at PKU Guanghua School of Management (2006-2013); associate professor at UNC Chapel Hill (2000–2006); and assistant professor at USC (1994–2000). He was the 2005-2006 President of the Chinese Economists Society, and the founding chair of Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Dr. Liu has served as Associate Editor for SCI journals Health Economics (HE), Value in Health (The ISPOR official journal), and China Economic Quarterly (CEQ).
Dr. Liu sits on The China State Council Health Reform Advisory Commission; the UN "Sustainable Development and Solution Network" (SDSN) Leadership Council led by Jeffrey Sachs of Columbia University, and Co-Chairs the SDSN Health Thematic Group.

Email：gordonliu@nsd.pku.edu.cn      Full CV

Office Phone Number：+86-10-58876178    
 

Recent Research Papers:

Myerson R., GG Liu, et al., “The Impact of Government Income Transfers on Tobacco and Alcohol Use: Evidence from China,” Economic Letters, forthcoming, 2019

Myerson R., GG Liu, et al., “Cancer Diagnosis and Care among Rural-to-Urban Migrants in China,” BMJ Global Health, forthcoming, 2019

Koch M., Butt T., Liu GG. et al., “Characterizing the population at-risk of COPD in China,” BMC Public Health, forthcoming, 2019.

Liu GG., Shepherd J. et al., “Characteristics of Patients with Dyslipidemia Treated in Routine Care Setting in China,” Journal of Drug Assessment, forthcoming, 2019.

Liu GG., Wu E. et al., “The Development of Health Technology Assessment (HTA) in Asia: Current Status and Future Trends,” Value in Health Regional Issues, forthcoming, 2019.

Yao Y, Liu GG. et al., “Disease and disparity in China: a view from stroke and MI disease,” International J for Equity in Health, forthcoming, 2019.

Liu GG. and Chen Xi, “China in transition: health, wealth, and globalization,” The LANCET Public Health, September 2019.

陈晨，刘国恩等，“中国老人接种流感疫苗的成本效果分析”，《中华预防医学杂志》，2019

王梦潇，刘国恩等，“中国医院管理调查中人才管理的现状分析”，《中国医院管理》，2019

Liu GG., et al., “How Much Does Social Status Matter to Longevity? – Evidence from China’s Academician Election,” Health Economics, 2015, forthcoming.
  
 Xuejing Jin., Liu GG., et al., “Is bad living better than good death? Impact of demographic and cultural factors on health state preference,” Quality of Life Research, 2015, forthcoming.
  
 Li Q, Liu GG., and Zang WB, “The Health of Left-behind Children in Rural China,” China Economic Review, 2015, forthcoming.
  
 Pan J., Lei XY, and Liu GG., “Health Insurance and Health Status: Exploring the Causal Effect from A Policy Intervention,” Health Economics, 2015.
  
 Wang P, Li MH, Liu GG, Thumboo J., and Luo N, “Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese,” European J of Health Economics, 2015 (16): 857–863.
  
 Fan M, Lei Z, and Liu GG., “Discounting of Medical Savings Accounts,”, American J of Health Economics, 2015, Forthcoming.
  
 Xu J., Liu GG. et al., “A comparison of outpatient healthcare expenditures between public and private medical institutions in urban China: an instrumental variable approach,” Health Economics, 2015(24): 270-279.
  
官海静，刘国恩，“中国城乡居民生命质量的比较研究，”《中国卫生经济》，2015(2);5-12.
  
 Liu GG., Chen YQ, and Qin XZ., “Transforming rural healthcare through information technology: an interventional study in China,” Health Policy and Planning, 2014 (8): 975-985.
  
 Liu GG., Wu HY., Li MH., Gao C., and Luo N., “Chinese time trade-off values for EQ-5D health states,” Value in Health, 2014 (17): 597–604.
  
周钦，刘国恩，“健康冲击：现行医疗保险制度究竟发挥了什么作用？”《经济评论》，2014（6）。
 
陆方文，高晨，徐菲，刘国恩，熊先军，“按人头付费与开放式首诊改革:基于城居保入户调查分析,”《中国卫生经济》，2014年6期。
 
潘杰，刘国恩，尹庆双，“医疗体制管办分开与服务供给，”《经济学报》，2014 （1）：33-50.
  
 Liu GG and Krumholz S., “Economics of health transition in China,” The Oxford Companion to the Economics of China, edited by Ravi Kanbur et al., Oxford University Press, 2014.
  
 Qin XQ, Pan J, and Liu GG., “Does participating in health insurance benefit the migrant workers in China? an empirical investigation,” China Economic Review, 2014 (30): 263-278.
  
 DiBonaventura M, Yuan Y, Lescrauwaet B, L'Italien G, Liu GG., “Multicountry burden of chronic hepatitis C viral infection among those aware of their diagnosis: A patient survey,” PLOS ONE, Jan 21, 2014.
  
黄源，刘国恩，刘跃华等，“精神分裂症的疾病经济负担：基于广州医保数据的分析，”《中国卫生经济》，2014(5): 62-65.
  
 Wu J., Xu J., Liu GG., “Pharmaceutical pricing: an empirical study of market competition in Chinese hospitals,” PharmacoEconomics, 2014 (32):293-303.
  
兰烯，刘国恩，李林，“医疗机构产权性质对医疗服务质量的影响，”《中国经济问题》，2014（2）：67-78.
  
 Gao C., Xu F., Liu GG., “Payment reform and changes in health care in China,” Social Science & Medicine, 2014 (111): 10-16.
  
 Chen G, Liu GG., and Xu F., "The impact of the urban resident basic medical insurance in China on health services utilization," PharmacoEconomics, 2014 (32): 277-292.
  
  
赵绍阳，臧文斌，傅十和，刘国恩，“强制医保制度下无保险人群的健康状况研究，”《经济研究》，2013 (7): 118-131.
  
刘国恩，“践行三中全会改革要义: 深化国家医改，谨防误读盲区，”《经济科学》，2013年第六期。
 
Li H., Liu GG., Glaetzer C., “Financing innovative medicines in China: the role of commercial health insurance,” Chinese Studies, 2013 (3): 128-133.
  
 Pan J., Liu GG., and Gao C., “How does separating government regulatory and operational control of public hospitals matter to healthcare supply?” China Economic Review, 2013 (27):1–14.
  
伍红艳，刘国恩，“生命质量量表不同计分方法对评价结果的影响，”《中国卫生经济》，2013 (8).
  
刘国恩，“转变经济发展方式靠什么：论两只看不见的手，”《比较》，2013（3）：130-144.
  
 Lai W, Hu S., Hou J, Liu GG., “A novel estimation of the impact of treatment with entecavir on long-term mortality, morbidity and healthcare costs of chronic hepatitis B in China,” Value in Health Regional Issues, 2013 (2):48-56.
  
樊敏杰，刘国恩，李林， “医疗机构产权性质对医疗费用的影响，”《中国经济问题》，2013 (5)：59-69.
  
刘国恩，官海静，高晨，“中国社会办医的现状分析，”《中国卫生政策研究》，2013（6）：41-46.
  
 Pan J, Qin X, Liu GG., "The impact of body size on urban employment: evidence from China." China Economic Review, 2013 (27): 249-263
  
 Luo N, Li M, Liu GG et al., “Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach,” Quality of Life Research, 2013(4): 885–890.
  
潘杰，雷晓燕，刘国恩，“医疗保险促进健康吗？”《经济研究》，2013 (4): 130-142.
  
 Qin XZ and Liu GG., “Does the U.S. healthcare safety net discourage private insurance coverage?” European J of Health Economics, 2013 (3): 457-469.
  
 Liu YJ, Xue YJ, Liu GG., and Ma AX., "Development of foreign invested hospitals in China: obstacles and coping strategies," Journal of Hospital Administration, 2013(2): 142-150.
  
 Zhao ZY, Liu GG., et al., “Hospital costs of adverse events in patients with metastatic colorectal cancer,” Journal of Cancer Therapy, 2013 (4): 153-158.
  
符一男，刘国恩，朱琳，马爱霞，“七价肺炎结合疫苗的药物经济学评价，”《中国卫生经济》, 2013(1).
  
官海静，刘国恩，熊先军， “城镇居民基本医疗保险对住院服务利用公平性的影响，”《中国卫生经济》，2013(1).
  
臧文斌，赵绍阳，刘国恩，“城镇基本医疗保险中逆向选择的检验，”《经济学季刊》，2012， 12（1）：47-70.
  
薛新东，刘国恩，“社会资本决定健康状况吗？”《财贸经济》，2012（8）:113-121 。
 
Liu GG et al., “The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan,” Value in Health, 2012, 15(1).
  
徐程，尹庆双，刘国恩，“健康经济学研究新进展，”《经济学动态》，2012（9）：120-127.
  
藏文斌，刘国恩，徐菲，“中国城镇基本医疗保险对家庭消费的影响，”《经济研究》，2012（7）：75-85。
 
秦学征，刘国恩， “医疗保险对劳动力市场的影响：综述分析，”《经济学动态》, 2011（12）:116-121。
 
Pan Jay and Liu GG, “The determinants of Chinese provincial government health expenditures: evidence from 2002-2006 data,” Health Economics, 2012(21): 757–777.
  
潘杰，秦学征，刘国恩，“体形对城市劳动力就业的影响，” 《南开经济研究》，2011；
 
刘国恩，蔡春光， 李林， “中国老人医疗保障与医疗服务需求的实证分析，”《经济研究》，2011(3): 95-107.
  
林莞娟，刘国恩等，“中国城镇居民基本医疗保险实施与评价，”《经济学报》，2010.
  
甘犁，刘国恩，马双， “基本医疗保险对促进家庭消费的影响，”《经济研究》，2010.
  
王鹏，刘国恩， “健康人力资本与性别工资差异，”《南方经济》，2010年（9）：73-84.
  
 Qiu Y., Fu A, Liu GG., and Christensen D., “Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Program,” Applied Health Economics and Health Policy, 2010, 8(3):167-177.
  
 Liu GG., Zhang SF ,and Zhang ZY., Investing in Human Capital for Economic Development in China, published by World Scientific, 2010.
  
 Liu GG., Fukuda T., Lee CE. et al., “Evidenced-based Decision Making on Medical Technologies in China, Japan, and Singapore,” Value in Health, 2009, 12(3): S12 - S17.
  
刘国恩, “全民医疗保障与保民生促增长,” 《理论前沿》, 2009, 16: 5-8.
  
 Liu GG., Li L., Hou X. et al., “The role of for-profit hospitals in medical expenditures: evidence from aggregate data in China,” China Economic Review, 2009, 20: 625-633.
  
 Lin W., Liu GG., and Chen G., “The Urban Resident Basic Medical Insurance: a landmark reform towards universal coverage in China,” Health Economics, 2009, 18:S83-S96.
  
 Liu GG., “Beijing’s perspective: the internal debate on health care reform,” published by the Center for Strategy and International Studies (CSIS), Washington DC., 2009.
  
刘国恩，唐燕，刘立藏，“城镇职工医疗保险政策研究：个人账户与医疗支出，”《财经科学》，2009.
  
李林，刘国恩，“我国营利性医院发展与医疗费用研究，”《管理世界》，2008, 10: 53-63.
  
 Liu GG., Eggleston K., and Hu TW., “Emerging health economics and outcomes research in Asian Pacific Region,” Value in Health, 2008, 11:s1-s2.
  
 Liu GG., Dow W., Fu AZ., Akin J., and Lance P., “Income productivity in China: on the role of health,” Journal of Health Economics, 2008, 22: 22-44.